Tag archive for ‘Xyosted prescription trends through September 20’
Antares: Impressive Xyosted Prescription Trends Continue (ATRS, Buy, $3.30)
Key Points: Xyosted prescription trends remain impressive and based on audit data for the last 11 weeks, there has been an acceleration in the trend line. My model has slightly increased its 2019 sales estimate from $18.8 million as shown in my August 27 report to $19.4 million and for 2020 from $53.9 to $56.8 […]